Sparrow Pharmaceuticals, Inc.

New Filing
CIK: 0001786949·Pharmaceuticals·DELAWARE·Filed: Jul 1, 2025
Total Offering

$121,400,027

Amount Sold

$61,841,225

Investors

17

First Sale

Jun 20, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Jacks
Related Person
Niall O'Donnell
Related Person
Zach Scheiner
Related Person
Peter Thompson
Related Person
Klaus Veitinger
Related Person
Nanna L?neborg
Related Person
Jonathan Root
Related Person

Company

Sparrow Pharmaceuticals, Inc.

1050 Southwest 6th Street

PORTLAND, OR, 97204

6174650328

SEC Filing

0001786949-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Sparrow Pharmaceuticals, Inc. Form D Filing — $121,400,027 | FilingFlow